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Abstract
Background: Regulatory T cells (Treg) play a crucial role in maintaining immune homeostasis and self-tolerance.
The immune suppressive effects of Tregs should however be limited in case effective immunity is required against
pathogens or cancer cells. We previously found that the Toll-like receptor 2 (TLR2) agonist, Pam3CysSK4, directly
stimulated Tregs to expand and temporarily abrogate their suppressive capabilities. In this study, we evaluate the
effect of Pam3CysSK4 and Legionella pneumophila, a natural TLR2 containing infectious agent, on effector T (Teff)
cells and dendritic cells (DCs) individually and in co-cultures with Tregs.
Results: TLR2 agonists can directly provide a co-stimulatory signal inducing enhanced proliferation and cytokine
production of naive CD4+ Teff cells. With respect to cytokine production, DCs appear to be most sensitive to low
amounts of TLR agonists. Using wild type and TLR2-deficient cells in Treg suppression assays, we accordingly show
that all cells (e.g. Treg, Teff cells and DCs) contributed to overcome Treg-mediated suppression of Teff cell
proliferation. Furthermore, while TLR2-stimulated Tregs readily lost their ability to suppress Teff cell proliferation,
cytokine production by Teff cells was still suppressed. Similar results were obtained upon stimulation with TLR2
ligand containing bacteria, Legionella pneumophila.
Conclusions: These findings indicate that both synthetic and natural TLR2 agonists affect DCs, Teff cells and Treg
directly, resulting in multi-modal modulation of Treg-mediated suppression of Teff cells. Moreover, Treg-mediated
suppression of Teff cell proliferation is functionally distinct from suppression of cytokine secretion.
Background
The immune system is of crucial importance to our
health and survival. Faced with pathogenic threats from
outside as well as the rise of cancer cells from within,
our immune defense must be able to cope with very
diverse opponents. Mammals have developed a diverse
set of receptors that sense components derived from
pathogens and damaged cells. Amongst the best studied
receptors are the so called pattern recognition receptors
(PRR) like the Toll-like receptor (TLR) family, RIG-I-
like receptor (RLR) family and the NOD-like receptor
(NLR) family of proteins [1]. In general, engagement of
these receptors on immune cells results in their activa-
tion, like enhanced antigen presentation, inflammatory
cytokine production and the acquisition of immune
effector function [2].
Pathogen recognition through specific TLRs can be of
crucial importance for the induction of protective
immunity. For instance, TLR4-deficient mice are more
susceptible for infections with Neisseria meningitidis,
E. coli, Haemophilus influenzae, Salmonella enteritidis,
and Klebsiella pneumonia [3]. In this regard, the immu-
nological effects of TLR2 ligation are remarkably differ-
ent compared to the other TLRs (reviewed by Netea et
al [3]). Firstly, TLR2 has been reported to direct the
broadest repertoire of danger-associated molecular pat-
terns from a large variety of pathogens, including gram-
positive and gram-negative bacteria, fungi, viruses, and
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parasites, but also endogenous proteins like Heat Shock
Protein 60 (HSP60) [4]. This broad range of recognition
may be explained by the heterodimerization of TLR2
with either TLR1 or TLR6. However, the recent publica-
tion of the TLR1/2 receptor-ligand crystal structure [5],
in combination with the extremely high affinity of TLR2
for its lipoprotein ligands [6], increases the possibility
that a number of putative TLR2-ligands have no intrin-
sic TLR2-activating capacities but were actually con-
taminated by lipoproteins [6]. Secondly, TLR2-deficient
mice are less susceptible to lethal infections with Asper-
gillus fumigatus, Yersinia enterocolitica or Candida albi-
cans, which is in contrast with e.g. TLR4-deficient mice
[7]. In TLR2-deficient mice, resistance to C. albicans is
mediated by a stronger Th1 response due to diminished
production of IL-10 during the infectious challenge [8].
The distinct roles of TLR2 and TLR4 in immunomodu-
lation was further emphasized by findings that TLR2-
deficient mice experienced increased joint inflammation
in preclinical rheumatoid arthritis (RA) models, while
TLR4-deficient mice were more resistant [9]. Interest-
ingly, the enhanced immunological responses in TLR2-
deficient mice correlate with decreased numbers of
Tregs in these mice [8]. Moreover, C. albicans induced
proliferation and survival of Tregs in a TLR2-dependent
manner [8].
Different types of Tregs have been characterized and
these Tregs are indispensable for the maintenance of
immunologic self-tolerance and immune homeostasis
[10]. The naturally occurring CD25+CD4+FoxP3+ Tregs
are generated in the thymus and constitute about 5-15%
of the peripheral CD4+ T cells in healthy animals and
humans [11-13]. Once naturally occurring Tregs are
activated via TCR-triggering, they are able to actively
suppress the function of multiple immune cells, such as
CD4+CD25-effector T cells (Teffs) and antigen present-
ing cells (APCs). Although these activities are essential
for maintaining tolerance and preventing autoimmunity,
their suppressive capacity may interfere with the devel-
opment of a potential anti-tumor/anti-pathogen immune
response, implicating the need for a mechanism that
regulates Tregs. We recently demonstrated that TLR2
triggering on Tregs by Pam3Cys in combination with T-
cell receptor (TCR) activation resulted in proliferation
of the otherwise non-proliferating Tregs and, impor-
tantly, the temporal abrogation of their suppressive cap-
abilities [14]. After a resting period, the Tregs regain
their suppressive, non-proliferative phenotype, indicating
this is a reversible process.
Since TLR2 is widely expressed in immune cells, we
now investigated the consequences of TLR2-signaling
on different immune subsets involved in adaptive
immune responses; APCs, Teffs and Tregs. We found
increased TLR2 expression on activated immune cells.
Interestingly, although TLR2 triggering abrogated Treg-
mediated suppression of Teff cell proliferation, TLR2
triggering was unable to restore effector cytokine secre-
tion. In addition, we show that Pam3Cys acts on Tregs,
Teffs and APCs to reverse the suppressive effects of
Tregs. Similar results were found with the pathogen
Legionella pneumophila (HKLP) containing potent TLR2
ligands [15-17], emphasizing the crucial role of TLR2 in
immunomodulation in infections.
Results
TLR2 expression and effects on Treg, Teffs and DCs
To decipher the role of TLR2 in immune responses in
more detail, the expression and function of TLR2 on
CD4+CD25+Foxp3+ Tregs, CD4+ Teffs and DCs were
studied. Expression of TLR2 is readily detected on the
cell surface of freshly isolated DCs (Figure 1A), while
expression on freshly isolated CD4+ Teffs and Tregs is
low or absent (Figure 1A). In line with the data from
Liu et al. [18], TLR2 expression is up-regulated upon
activation of these T cells (data not shown), and both
CD4+ T cell populations continue to express TLR2
when cultured for several weeks with CD3 and Pam3Cys
(Figure 1B).
Since the expression of TLR2 on these T cell subsets
seems to be affected by their activation state, we investi-
gated how TLR2 expression correlated to the functional
responsiveness of DCs, Teffs and Tregs to the TLR2
ligand Pam3Cys. As shown in Figure 2, both freshly iso-
lated Tregs and naive Teffs showed enhanced prolifera-
tion after CD3 stimulation in the presence of increasing
amounts of TLR2-ligand, indicating Pam3Cys
co-stimulated these T cells. In the absence of CD3 sti-
mulation, no proliferation was observed on either Teffs
or Tregs (data not shown), which is in line with the
absence of TLR2 up-regulation on these cells. Analysis
of the cultured CD4+ T cell subsets revealed that only
the cultured Tregs, not the cultured Teff cells, remained
responsive towards TLR2 stimulation. This finding is
consistent with our current understanding that primed
Teff cells become less dependent on co-stimulatory sig-
nals, as has been described for CD28 stimulation.
TLR2-triggering was also highly effective in co-
stimulating cytokine secretion in CD3-activated, freshly
isolated Teff cells (Figure 3). They predominantly pro-
duced IL-2, IL-10, IL-4 and IFNg, and cytokine produc-
tion was gradually increased with increasing Pam3Cys
concentrations. As expected, freshly isolated Tregs did
not produce any detectable levels of these cytokines
(data not shown). Also the in vitro expanded Tregs did
not produce any cytokines while the in vitro cultured
Teff cells (Figure 3) already produced high amounts of
cytokines in the absence of Pam3Cys (i.e. only in the
presence of anti-CD3). Adding increasing amounts of
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Pam3Cys to these Teff cells did not significantly affect
cytokine production.
Analysis of Pam3Cys-stimulated DCs indicated that
they readily produce multiple cytokines, including high
amounts of IL-6 and IL-12p40 (Figure 4). Maximal cyto-
kine production by DCs already reaches a plateau at rela-
tively low amounts of Pam3Cys (0.1 μg/ml). Overall, the
TLR2-induced cytokine profiles of the freshly isolated
Teff cells and the DCs nicely correlate with a cytokine
profile needed for the induction of an immune response
[19-22]. Collectively, these results show that Tregs, DCs
as well as Teffs can express functional TLR2. DCs are
most capable of sensing low amounts of TLR2 ligand. In
agreement with the current understanding that activated
Teff cells are less dependent of (co-)stimulation, we show
that they are less sensitive to TLR2 co-stimulation than
naive Teff. In contrast, Treg remain relatively unrespon-
sive to TCR stimulation and rely on co-stimulation in
order to enter a proliferative state.
Effect of TLR2 triggering on Treg function
Recently, we as well as others reported that triggering of
TLR2 on murine Tregs with a relatively high dose of
Pam3Cys in combination with TCR signaling induced
significant proliferation in the otherwise non-proliferative
Treg subset [14,18]. Strikingly, Treg proliferation was
accompanied by a temporal loss of the ability of the
Tregs to suppress the proliferation of the Teff cells. To
analyze the effects of TLR2 on Treg function in more
detail, we titrated increasing concentrations of the TLR2-
ligand Pam3Cys in a suppression assay and determined
its impact on Teff cell proliferation and on cytokine
production, using CFSE-labeled TLR2-deficient Teff cells
co-cultured with wildtype Tregs. In contrast to 3H-
tritium-Thymidine incorporation assay, the use of CFSE-
labeled Teff cells allows to distinguish between Treg and
Teff proliferation. As shown in Figure 5A (representative
raw data are shown in Additional file 1), very low TLR2-
ligand concentrations (<0.2 μg/ml) hardly affected the
Figure 1 TLR2 expression profile on fresh and cultured immune cells. (A) Dendritic cells (CD11c+), CD4+CD25+Foxp3+ Treg and CD4+
effector T cells (Foxp3-) were isolated from spleens of naïve mice and immediately analyzed for TLR2 surface expression by flow cytometry (grey
line, isotype control; black line, TLR2 antibody). TLR2 is expressed on freshly isolated DCs, while expression on Teff and Treg is absent or low.
(B) Treg and Teff were cultured in the presence of Pam3Cys, anti-CD3 and irradiated splenocytes as APCs for several weeks (see materials and
methods). Activation induced TLR2 expression on both Treg and Teff which remained high when cultured for several weeks. Representative
results of 3 independent experiments are shown, all experiments were performed in duplicate.
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Treg mediated suppression of Teff proliferation. In line
with our previous results, a higher dose of TLR2-ligands
(>2 μg/ml) induced a clear loss of Treg suppressive activ-
ity as reflected by increased Teff proliferation. The addi-
tion of Tregs to the Teff cell cultures blocked
proliferation as well as cytokine production. In contrast
to its effect on proliferative capacity, the addition of
Pam3Cys to these cultures failed to restore cytokine pro-
duction by Teffs (Figure 5B). These results indicate that
with respect to Treg mediated suppression of Teff cells,
suppression of proliferation and suppression of cytokine
production should be regarded as two separate events.
Effect of TLR2 triggering on immune cell subsets on Treg
mediated immune suppression
To determine the contribution of TLR2 triggering on
the different cell types present in a suppression assay
(Tregs, Teffs and APCs), we performed suppression
assays combining cells isolated from TLR2-deficient
mice and wildtype mice. This setup ensures that any of
the observed effect of the TLR2-ligands is mediated
through TLR2 triggering on the cells purified from the
wildtype mice. We focused on Treg-mediated suppres-
sion of Teff proliferation as the read out system.
TLR2 triggering on wildtype Tregs in the presence of
TLR2-deficient Teff and APC resulted in a 57% reduc-
tion in the suppression of Teff cell proliferation (Figure
6A). Similarly, TLR2-signaling on Teffs (TLR2-deficient
Tregs and DCs) or DC (TLR2-deficient Teff and Treg)
inhibited Treg-mediated suppression to 55% and 65%
respectively. A similar level of reduction in suppression
was also observed when all cells were derived from wild-
type origin. Control suppression assays performed with
only TLR2-deficient cells demonstrated the specificity of
the TLR2-effect (Figure 6B). These data thus demon-
strate that TLR2 is important in controlling activation
Figure 2 Effect of Pam3Cys titration on proliferation of fresh versus cultured Tregs and Teff cells. Teff and Treg were freshly isolated
from spleen or cultured for weeks and stimulated with different concentrations of Pam3Cys in the presence of 1 μg/ml anti-CD3. After 4 days
proliferation was determined using thymidine incorporation (relative expression compared to anti-CD3 alone). The condition without Pam3Cys is
set to 1 and the conditions with Pam3Cys are related to this condition. The absolute cpm levels of the cells with (5 ug/ml) and without
Pam3Cys are for cultured Teffs 13383 cpm vs 7456 cpm, for fresh Teffs 31076 cpm vs 6693 cpm, for fresh Treg 15590 cpm vs 3776 cpm, and
cultured Treg 16642 cpm vs 4936 cpm. Freshly isolated Tregs and Teff cells showed increased proliferation upon TLR2 stimulation, while only
cultured Tregs (not cultured Teff) remained sensitive to TLR2 triggering. Representative results of 3 independent experiments are shown. The
error bars represent standard deviations of triplicate measurements.
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of immune cells and that TLR2 acts on each of the
three cell types present in the suppression assay; Tregs,
Teffs and APCs.
Effect of Legionella pneumophila on immune cell
proliferation, cytokine production and Treg suppression
So far, the experiments were performed with the synthetic
TLR2 ligand Pam3Cys. We repeated these experiments
with the natural pathogen Legionella pneumophila, which
is known to contain high amounts of TLR2 ligands [23].
As shown in Figure 7, the proliferative capacity of the cul-
tured Teff cells and Tregs were similar to the data found
with Pam3Cys. The cultured Teff cells were hardly respon-
sive to the HKLP, and this did not change upon increasing
pathogen concentration. The naive CD4+ Teff cells were
highly responsive to HKLP in a dose-dependent manner.
Both freshly-isolated and cultured Teff produced IFN-g
upon HKLP stimulation (Figure 8).
To further investigate the effect of HKLP on Treg,
suppression assays were performed. The results shown
in Figure 9 indicate that HKLP abrogated the Treg-
mediated suppressive capacity even in conditions where
Tregs are the only TLR2 expressing cells. These data
imply that the immune modulatory effect of Pam3Cys
can be mimicked by a natural pathogen containing high
amounts of TLR2 ligand. It is likely that during normal
infections of Legionella pneumophila the suppressive
capacity of the Tregs can at least in part be abrogated
by directly acting on the Tregs themselves.
Discussion
The complexity of signals received and produced by our
immune system has puzzled immunologist for many
years. The re-discovery of the suppressor T cells mostly
indicated as Tregs has increased our comprehension of
immunity in health and disease. In immune homeosta-
sis, immune activation events are kept in balance by
many regulatory mechanisms like suppressors of cyto-
kine signaling (SOCS), CTLA-4, suppressive cytokines
like IL-10 and TGF-b, and importantly Tregs. However
during infections, strong immune activation signals are
released, including a set of pathogen-associated molecu-
lar patterns. These pathogen derived determinants are
able to induce the activation of amongst others TLRs,
one of the main families of receptors involved in pattern
recognition. This will result in a strong inflammatory
immune response capable of dealing with the patho-
genic challenge. More recently, TLR agonists have been
shown to also act directly on Treg and ‘lift’ the suppres-
sive pressure on other immune cells. We demonstrated
that TLR2 triggering on Tregs in combination with TCR
signaling induces proliferation of the Tregs and reduces
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Figure 3 Cytokine production of Teffs upon TLR2-triggering. Freshly isolated and cultured Teff were stimulated with anti-CD3 and
increasing concentrations of Pam3Cys. Fresh Teff were additionally cultured in the presence of irradiated APCs that did not produce these
cytokines upon stimulation (data not shown). Freshly isolated Teff showed a clear dose dependent increase in IL-2, IL-4, IL-10 and IFNg. Cultured
Teff cells produced high amounts of cytokines in the absence of Pam3Cys and failed to show a clear effect of Pam3Cys. All cytokine profiles
were determined by Luminex analyses. Representative results of 2 independent experiments are shown, all experiments were performed in
duplicate.
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their suppressive capacity [14]. Similar data were later
reported by Liu et al. [18]. Recently Oberg et al. [24],
examined the influence of different TLR2 ligands on
human Tregs. They show similar results for 75% of the
used human donors, namely direct abrogation of the
Treg suppressive capacity. They also observed individual
differences in efficacy between different TLR2 ligands.
Above all, Zhang et al. [25] currently tested the abroga-
tion of Treg-mediated suppression in an in vivo tumor-
bearing mouse model. They report that injection of the
mice in combination with pretreatment of the Treg cells
with Pam3Cys, induces a marked reduction of Treg cells
in the lymph nodes and a diminished suppressive activ-
ity of the remaining Tregs present in these mice. On the
contrary, another researcher group has published that
TLR2 does not abrogate the Treg suppressive function
[26]. The different findings might be explained by the
difference in model systems, cell sources, experimental
setups and as described by Oberg et al. [24] the expres-
sion pattern of TLR1/TLR2.
The loss of suppression by TLR2 triggering on Treg
facilitates the induction of adaptive immune responses.
At the same time, TLR2-stimulated Tregs expand and
have been suggested to limit excessive tissue pathology
and to prevent potential autoimmune events once the
pathogen is efficiently cleared. To further assess the role
of TLR2, we investigated the effects of TLR2 stimulation
on Treg and other immune cells known to be involved
in the adaptive immune response; Teff cells and the pro-
fessional antigen presenting DCs. Freshly isolated sple-
nic DCs express TLR2, but the freshly isolated Tregs
and Teff cells only express TLR2 upon activation. Inter-
estingly, all freshly isolated cells respond to the TLR2-
ligand Pam3Cys, however after in vitro culturing, only
the Tregs remained responsive to TLR2-stimulation in
lower concentrations. TLR2 on naive Teff cells
enhanced Teff cell proliferation indicating that TLR2
acts as a co-stimulatory signal, similar to CD28. Cul-
tured Teff cells did not seem to respond to TLR2 trig-
gering. These data are in line with the idea that primed
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Figure 4 Cytokine production of DCs upon TLR2-triggering. Production of IL-6, IL-12, IL-10 and IL-8 by DCs after stimulation with Pam3Cys.
All cytokine profiles were determined by Luminex analyses. Representative results of 2 independent experiments are shown, all experiments
were performed in duplicate.
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Figure 5 TLR2 triggering effects Treg suppression. (A) Suppression assays were performed with wild type Treg and TLR2-deficient Teff in the
absence or presence of Pam3Cys, in which the read-out is Teff cell proliferation. Pam3Cys inhibited Treg-mediated suppression in a dose-
dependent manner. (B) Analysis of the effect of Pam3Cys on IL-2, IL-4, IL-10 and IFNg cytokine production. Increasing concentrations of Pam3Cys
did not restore cytokine production (nd, not detectable). Data representative of 2 experiments are shown. The error bars represent standard
deviations of duplicate measurements.
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Teff cells are less dependent on co-stimulation by TLR2,
similar to co-stimulation by CD28, though the anergic
Treg subset requires more than TCR triggering alone in
order to enter a state of proliferation.
When analyzing the effects of TLR2-stimulation of
Tregs in more detail, we observed a difference between
suppression of proliferation and suppression of cytokine
production by the Treg. Interestingly, TLR2-treated
Treg still suppressed cytokine secretion, but lost their
ability to suppress the proliferation of Teff cells. Appar-
ently, the process of suppression of cytokine secretion is
different from that of suppression of proliferation. This
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Figure 6 Treg suppression assay using wildtype and TLR-2 knockout cell types. (A) Suppression assays were performed with different
combinations of wildtype and TLR2-deficient Treg, Teff or APCs. In each experiment only one of the three cell types was derived from wild type
mice and thus able to respond to Pam3Cys. Data show that Pam3Cys released Treg-mediated suppression in every condition and hence affected
all cell types directly. (B) Suppression assays with all cells being either TLR2 knockout or wildtype show maximal suppression and maximal
release from Treg mediated suppression, respectively. Representative results of 2 experiments are shown. The error bars represent standard
deviations of duplicate measurements.
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is in line with data of Shevach et al. showing that
mature DCs abrogated Treg-mediated suppression of
Teff cell proliferation, while cytokine secretion was still
suppressed [10]. Moreover, DCs stimulated the prolif-
eration of Treg, similar as observed after TLR2 stimula-
tion. It remains intriguing why such highly different
signals (TLR2 versus mature DCs) would yield similar
phenotypes in the Tregs. One possibility would be that
the Tregs require a certain threshold of co-stimulatory
signals. Indeed, it has been shown that TLR2 can substi-
tute for CD28 with respect to co-stimulatory signals
required for T cell stimulation [21]. Once the combina-
tion of co-stimulatory signals and TCR triggering is suf-
ficient, the Treg will suppress only cytokine secretion by
Teff and will start to proliferate themselves. Why would
Treg allow Teff proliferation whilst inhibiting Teff cyto-
kine production? Possibly cytokine secretion is a far
more dangerous effector mechanism as compared to
Teff proliferation.
Since TLR2 effected suppression of proliferation, we
addressed the effects of TLR2 on each of the cellular
subsets present during the suppression assay. Our
results show that TLR2 can abrogate the suppression of
proliferation by acting on each subset being Treg, Teff
or DC. TLR2 triggering on Treg induces their prolifera-
tion and temporal inhibition of their suppressive capa-
city, while on Teff cells TLR2 has a co-stimulatory role.
TLR2 triggering on DCs results in the production of
cytokines like IL-6 that have been shown to release Teff
from Treg mediated suppression [27]. We examined IL-
6 production in our co-culture experiments combining
Teffs, Tregs and DCs for wild type and TLR2-knock out
origin (data not shown). Although the presence of IL-6
coincides with the abrogation of Treg-mediated suppres-
sion of Teff proliferation in the wild type conditions,
Teffs also start to proliferate when Teffs/DCs are TLR2-
deficient. We therefore conclude that IL-6 is able to sti-
mulate the proliferation of Teffs but is not absolutely
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Figure 7 Effect of HKLP titration on proliferation of fresh versus cultured Teff cells and cultured Tregs. Cells were stimulated with
different concentrations of HKLP in the absence or presence of anti-CD3. After 4 days proliferation was determined by analyses of thymidine
incorporation (A) or CFSE dilution, displayed as MFI values (B). Cultured Treg proliferated in response to HKLP in a dose-dependent manner.
Freshly isolated Teff also slightly responded to HKLP, while no effects were observed in cultured Teff. Representative results of 3 independent
experiments are shown. The error bars represent standard deviations of duplicate measurements.
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required for abrogation of Treg-mediated suppression of
Teff proliferation. By acting on all multiple immune cell
subsets involved in adaptive immunity, TLR2 stimula-
tion launches an effective immune response. A potent
increase of regulatory mechanisms will have to occur to
suppress any potential autoimmune events. The
observed expansion of Tregs following immune activa-
tion shown here and in our previous work represents
one of these feed-back mechanisms. The increased
expansion of Treg may prevent immune pathology and
help to dampen the immune response once the cause of
the immune challenge has been eliminated.
The question arose whether the effect of synthetic
TLR2 ligand could also be observed during natural
infections. The gram-negative micro-organism Legio-
nella pneumophila is the causing agent of a severe
pneumonia. Immune recognition of this microorganism
has been reported to be dependent on TLR2 signaling
and not on TLR4 signaling [15,16]. Therefore we
repeated the experiments with heat-killed Legionella
pneumophila (HKLP) to confirm our Pam3Cys findings.
Indeed the effect of TLR2 triggering on all different
immune cells could be confirmed when using HKLP in
our assays. Most importantly the suppressive capacity of
Figure 8 IFNg cytokine production by HKLP stimulation. Cultured Teff cells and freshly isolated Teff cells were stimulated with 10^9 CFU/ml
HKLP in the absence or presence of anti-CD3. Representative results of 2 independent experiments are shown. The error bars represent standard
deviations of duplicate measurements.
Figure 9 Treg suppression with HKLP stimulation. Suppression assays were performed with two combinations of wildtype and TLR2-deficient
cells. When all cells were from wildtype mice both Pam3Cys and HKLP inhibited Treg-mediated suppression (left panel). Similar results were
obtained when TLR2-deficient Teff and APC were cultured in the presence of wildtype Treg, indicating that HKLP acted on the Treg themselves.
Representative results of 2 experiments are shown. The error bars represent standard deviations of duplicate measurements.
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the Tregs could be abrogated in the presence of HKLP.
These data indicate that TLR2 triggering potently mod-
ulates immune function during bacterial infections.
However, it should be considered that besides effects on
TLR2, stimulation of other pathogen recognition recep-
tors could drastically influence the outcome of induced
immune responses against specific pathogens. Recogni-
tion of Legionella pneumophila is mainly relying on
TLR2 triggering. Other pathogens likely trigger other
receptors that could possibly effect Treg suppression.
Conclusions
Our findings indicate that Treg-mediated suppression of
T helper cell proliferation is functionally distinct from
suppression of cytokine secretion. TLR2 acts on multiple
cells of the adaptive and innate immune system thereby
providing direct immune stimulation of Teffs and DCs
while simultaneously inhibiting the suppressive abilities
of Tregs. These effects are not only observed for a syn-
thetic TLR2 ligand, but could be confirmed with the
natural TLR2 ligand containing bacteria Legionella
pneumophilia. Further understanding of the precise
mechanisms involved, will most likely contribute to new
strategies for immune-based intervention strategies.
Methods
Mice
The wildtype C57BL/6 mice were obtained from Charles
River WIGA (Sulzfeld, Germany) Gmbh. TLR2 knock-
out on C57BL/6 background mice were kindly obtained
from S. Akira (Osaka University, Osaka, Japan). All ani-
mal experiments were approved by the Animal Experi-
mental Committee of Radboud University Nijmegen
Medical Centre and were performed in accordance with
institutional and (inter)national guidelines.
Antibodies and flow cytometry
Directly labeled monoclonal antibodies used for staining
by anti-CD4-APC or -FITC (clone L3T4), anti-CD25-
FITC or -PE (clone 7D4), anti-CD11c-FITC (HL3), anti-
Streptavidin-PerCp, and their isotype controls were
obtained from BD Biosciences - Pharmingen. Anti-
mTLR2-biotine (clone T2.5), anti-mFoxP3-biotine (clone
FJK-16S) and the isotype control were obtained
from eBioscience. Analysis of cell surface markers on
lymphocytes was performed using FACScalibur (BD)
and CELLQuest software (version 3.3; BD Biosciences -
Pharmingen).
T cell purification and analysis
Spleens from wildtype or TLR2 knockout mice were
mashed and filtered, and CD4+ T cells were purified
using anti-mouse-CD4 Microbeads (MACS, Miltenyi
Biotec), resulting in a enriched CD3+CD4+ T cell
population. Naive CD4+CD25low Teff cells and naive
CD4+CD25high Treg cell subsets were obtained by flow
cytometry purification of the pre-sorted CD4+ T cells;
CD4 cells were stained with FITC-conjugated CD4 mAb
(BD bioscience, clone L3T4) and PE-conjugated CD25
(BD biosciences, clone 7D4). Cell sorting was performed
on a Coulter Altra HyPerSort cell sorter. Both naive
CD4+CD25low T cells and naive CD4+CD25high
T cells were 98% pure, based on CD25 expression pat-
tern. Determining the purity by using biotinilated-FoxP3
Ab (eBiosciences, clone FJK-16S) and streptavidine-
PerCp Ab (BD bioscience) showed that from the
CD25high FACSsorted cells, 67% of the cells were
FoxP3+, therefore Tregs. Sorted cells were used directly
in several assays or kept in culture as described below.
After several weeks of culture the purity of the Treg cell
line as well as the Teff cell line (referred in this paper to
the cultured Tregs or cultured Teff cells) was 96% or
higher (see Additional file 2).
Treg and Teff cell culture and suppression assay
FACS-sorted purified CD4+CD25+ T cells and CD4
+CD25-T cells are kept in culture for several weeks.
Each cell-line is cultured in 10^4 cells per well of a 96-
well plate, and were stimulated weekly with 5*10^4 irra-
diated CD4-MACS bead depleted splenocytes per well,
in 2 μg/ml Pam3Cys (EMC microcollections, Germany),
1 μg/ml anti-CD3 (145-2C11; BD Biosciences - Phar-
mingen), and 120 IU (international units) IL-2/ml com-
plete medium. The cells were washed 3 days after each
stimulation and maintained in culture medium supple-
mented with 120 IU IL-2/ml. When necessary, dead
cells were removed by ficoll density gradient. Cultured
Tregs or Teff cells were used in assays at least 6 days
after stimulation, in this case the Tregs and Teff cells
are in a resting state when used in all assays.
Suppression assays were performed as follows; freshly
sorted (wildtype or TLR2 knockout) CD4+CD25-naive
T cells (20*10^3 per well) and either cultured or freshly
isolated (wildtype or TLR2 knockout) Tregs (20*10^3
per well) were mixed and cocultured for 3 days with
20*10^3 irradiated (wildtype or TLR2 knockout) APCs
per well. If indicated, the T cells were stimulated with
TLR ligand Pam3Cys (5 μg/ml, EMC microcollections
GmbH) or HKLP (10^6-10^9 CFU/ml of heat-killed
Legionella pneumophila; InvivoGen) with or without
soluble anti-CD3 (1 μg/ml, 145-2C11; BD Biosciences -
Pharmingen) in complete medium. After 3 days of
coculture, supernatant was collected for cytokine analy-
sis. In addition, the suppression of proliferation was
monitored by analyzing the CFSE-labeled (1 μM) freshly
sorted (wildtype or TLR2 knockout) CD4+CD25-naive
T cells. CFSE fluorescence intensity was measured by
flow cytometry.
van Maren et al. BMC Immunology 2011, 12:23
http://www.biomedcentral.com/1471-2172/12/23
Page 11 of 13
Calculation of suppression
The amount of suppression is calculated by the
amount of proliferation or cytokine production. In
each assay we include 5 conditions (see Additional
file 3) by which we calculate the suppression, using
the mean fluorescent intensity of the CFSE-labeled
Teff cells. The first condition (background) is a cocul-
ture of CFSE-labeled Teff cells, APCs and anti-CD3
stimulation (1 μg/ml). This condition indicates the
level of Teff cell proliferation induced by anti-CD3 in
the presence of APC. The second condition (0% sup-
pression) is a coculture of CFSE-labeled Teff cells,
APCs, anti-CD3 stimulation (1 μg/ml) and Pam3Cys
(concentration used between 10 to 0.01 μg/ml). This
condition represents maximum of Teff cell prolifera-
tion. The next condition consists of a coculture of
CFSE-labeled Teff cells, APCs, Tregs and anti-CD3
stimulation (1 μg/ml), which is used to achieve maxi-
mal suppression (set to 100% as a reference). The last
condition consists of a coculture of CFSE-labeled Teff
cells, APCs, Tregs, anti-CD3 stimulation (1 μg/ml)
and Pam3Cys (concentration used between 10 to 0.01
μg/ml), indicated as ‘x% suppression’. This x% sup-
pression is calculated by the following formula; ((MFI
x% - MFI 0%)*100)/(MFI max - MFI 0%). For all data
presented the difference between the 0% suppression
and max suppression was at least 150 in MFI. In the
case of cytokine production, we used the same for-
mula with amount of cytokines produced as principle
parameter.
Cytokine measurements
For the detection of cytokines in culture supernatant we
used the Mouse Th1/Th2 Bio-Plex Cytokine Assay
(#171-F11081, Bio-Rad, Hercules, CA). All procedures
were performed according to the manufacturer’s
instructions.
Proliferation assay
Freshly FACS-sorted or cultured CD4+CD25+Treg and
CD4+Tconv cells were cultured for 4 days with a range
of Pam3Cys concentrations (between 0 μg/ml-5 μg/ml)
or HKLP (10^6-10^9CFU/ml of heat-killed Legionella
pneumophila; InvivoGen) with or without soluble CD3
stimulation (1 μg/ml). After 4 days the proliferation
was measured by overnight (20 hours) thymidine
incorporation.
Statistical analysis
The data are analysed using a one-way ANOVA test, to
test the differences between groups (PRISM software
version 4.0; GraphPad, San Diego, CA, USA). Statistical
significance is inferred at P < 0.05. Significant differ-
ences are indicated with an asterisks (*).
Additional material
Additional file 1: Suppression assay with increasing Pam3Cys
concentrations. Suppression is determined by CFSE dilution of the naive
Teff cells. These data show the CFSE peaks obtained after 3-4 days
culture with or without Pam3Cys (5 μg/ml). Loss of Treg-mediated
suppression resulted in more Teff proliferation, indicated by a peak shift
to the left.
Additional file 2: Purity of isolated Tregs and Teffs. The Teff cells and
Tregs were MACS-sorted from total splenocytes based on CD4
expression and thereafter FACS-sorted into CD25 high or low expressing
cells. After several weeks in culture, the purity of Teff and Treg was 98%
and 96% respectively.
Additional file 3: Conditions used in suppression assay. This list
shows all conditions always used in suppression assays, and which cells/
stimulations are in each condition.
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